Inventor · disambiguated record
Stephen Brand
Also filed as: BRAND STEPHEN · BRAND STEPHEN J
25 granted patents·14 pending applications·443 citations·filing 1992–2022
96Inventor score
Files withWARATAH PHARMACEUTICALS INC9UCB PHARMA SA5CELLTECH R&D LTD4MILLENNIUM PHARM INC3BRAND STEPHEN2
Top patents by PatentIndex Score
39 records- 0188US6271199B2Treatment of infarctsMILLENNIUM PHARM INC·Filed 1998·Granted Aug 7, 2001·70 cites·24 claims
- 0287US6878718B2Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2002·Granted Apr 12, 2005·17 cites·8 claims
- 0385US5693617AInhibitors of the 26s proteolytic complex and the 20s proteasome contained thereinPROSCRIPT INC·Filed 1995·Granted Dec 2, 1997·56 cites·22 claims
- 0483US6872719B1Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2003·Granted Mar 29, 2005·18 cites·8 claims
- 0582US6835738B1Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2003·Granted Dec 28, 2004·17 cites·6 claims
- 0682US5885956ATreatment for diabetes using a gastrin/CCK receptor ligand and an EGF receptor ligandRES TRIANGLE PHARM LTD·Filed 1992·Granted Mar 23, 1999·46 cites·9 claims
- 0781US9156811B2N-myristoyl transferase inhibitorsBRAND STEPHEN·Filed 2009·Granted Oct 13, 2015·9 cites·3 claims
- 0881US7501437B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2007·Granted Mar 10, 2009·3 cites·24 claims
- 0981US7037504B2Epidermal growth factor protein and gene, and methods of use thereforWARATAH PHARMACEUTICALS INC·Filed 2001·Granted May 2, 2006·19 cites·49 claims
- 1080US7122556B2Phenylalanine enamide derivativesCELLTECH R&D LTD·Filed 2004·Granted Oct 17, 2006·9 cites·25 claims
- 1180US6613541B1Method for monitoring proteasome inhibitor drug actionMILLENNIUM PHARM INC·Filed 1999·Granted Sep 2, 2003·68 cites·30 claims
- 1278US6992060B2Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetesWARATAH PHARMACEUTICALS INC·Filed 2002·Granted Jan 31, 2006·35 cites·10 claims
- 1376US7645770B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2008·Granted Jan 12, 2010·1 cites·21 claims
- 1475US7786177B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2009·Granted Aug 31, 2010·1 cites·23 claims
- 1575US7531549B2Phenylalanine enamide derivativesUCB PHARMA SA·Filed 2006·Granted May 12, 2009·1 cites·24 claims
- 1675US6558952B1Treatment for diabetesWARATAH PHARMACEUTICALS INC·Filed 1999·Granted May 6, 2003·30 cites·3 claims
- 1774US6288301B1Treatment for juvenile diabetesWARATAH PHARMACEUTICALS INC·Filed 1998·Granted Sep 11, 2001·36 cites·15 claims
- 1870US7560425B2Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetesWARATAH PHARMACEUTICALS INC·Filed 2003·Granted Jul 14, 2009·3 cites·9 claims
- 1969US2009036381A1Treatment of diabetesWARATAH PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2066US9828346B2N-myristoyl transferase inhibitorsUNIV DUNDEE·Filed 2015·Granted Nov 28, 2017·1 cites·12 claims
- 2165US7557130B2Bicyclic heteroaromatic alaninesUCB PHARMA SA·Filed 2002·Granted Jul 7, 2009·3 cites·13 claims
- 2264US7476388B2Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligandWARATAH PHARMACEUTICALS INC·Filed 2005·Granted Jan 13, 2009·0 cites·11 claims
- 2361US2009041731A1Treatment for DiabetesPARIKH INDU·Filed 2008·Application pending·0 cites
- 2458US2004209801A1Treatment of diabetesFiled 2003·Application pending·0 cites
- 2557US12509439B2Anti-malarial agentsUNIV KENTUCKY RES FOUND·Filed 2021·Granted Dec 30, 2025·0 cites·20 claims
- 2657US2006189520A1Treatment of diabetesBRAND STEPHEN J·Filed 2003·Application pending·0 cites
- 2757US2003069189A1Treatment of infarctsMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2855US2001053760A1Treatment of infarctsFiled 2001·Application pending·0 cites
- 2955US2009269337A1Compositions and methods for treating diabetesWARATAH PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3054US2004209816A1Treatment for diabetesFiled 2004·Application pending·0 cites
- 3153US2007098685A1Methods and kits to treat chronic inflammatory immune diseases by administering a proteasome inhibitor and an interleukin 2 receptor agonistBRAND STEPHEN J·Filed 2006·Application pending·0 cites
- 3250US2024425491A1Heteroaryl compounds useful in the treatment of cognitive disordersUNIV COLLEGE CARDIFF CONSULTANTS LTD·Filed 2022·Application pending·0 cites
- 3348US2002081285A1Treatment for diabetesFiled 2001·Application pending·0 cites
- 3447US2007066520A1Novel epidermal growth factor protein and gene, and methods of use thereforWARATAH PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3546US2011182903A1Novel soluble cd83 polypeptides, formulations and methods of useBRAND STEPHEN·Filed 2009·Application pending·0 cites
- 3644US8324204B2Fused thiophene derivatives as kinase inhibitorsALEXANDER RIKKI PETER·Filed 2007·Granted Dec 4, 2012·0 cites·6 claims
- 3741US2004037818A1Treatment for diabetesFiled 2003·Application pending·0 cites
- 3837US10479792B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Nov 19, 2019·0 cites·24 claims
- 3933US10065965B2Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agentsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Sep 4, 2018·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Stephen Brand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →